Astrazeneca Pharma India Ltd
BSE:506820
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Astrazeneca Pharma India Ltd (506820) under the Base Case is INR per share.
Compared with the current market price of 6 511.1001 INR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Astrazeneca Pharma India Does
AstraZeneca Pharma India Ltd sells prescription medicines in India, with a focus on specialty drugs for areas such as oncology, cardiovascular and kidney care, respiratory disease, and other chronic conditions. It does not manufacture most of these drugs in the way a generic maker does; instead, it markets and distributes branded medicines developed by the AstraZeneca group and supports doctors and healthcare providers with product information and medical education.
- Headquarters
- India IN
- Employees
- 600
- IPO date
- Jul 30, 1998
Revenue & Expenses Breakdown
Astrazeneca Pharma India Ltd
Earnings Waterfall
Astrazeneca Pharma India Ltd
What is the Intrinsic Value of one ASTRAZEN stock?
The intrinsic value for Astrazeneca Pharma India Ltd (506820) under the Base Case is INR.
Is ASTRAZEN stock undervalued or overvalued?
Compared with the current market price of 6 511.1001 INR, the stock appears .
